12:00 AM
Nov 12, 2015
 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: MicroRNA-10b (miR-10b)


In vitro and mouse studies suggest an miR-10b inhibitor plus doxorubicin could help treat metastatic breast cancer. Levels of miR-10b were higher in human metastatic breast cancer cell lines and in primary tumors from patients with metastatic...

Read the full 168 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >